Answer
Faricimab (Vabysmo) is indicated in adults for neovascular (wet) age-related macular degeneration and visual impairment due to diabetic macular oedema or macular oedema secondary to branch or central retinal vein occlusion.
Sources for this answer
- Vabysmo 120 mg/mL solution for injectionRoche Products Limited · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked